Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 20, 2025
Crinecerfont.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: March 04, 2025
Efficacy and safety of crinecerfont for the treatment of congenital adrenal hyperplasia.
Journal: European journal of internal medicine
Published: December 24, 2024
Crinecerfont in Adult Congenital Adrenal Hyperplasia. Reply.
Journal: The New England journal of medicine
Published: October 23, 2024
Crinecerfont in Adult Congenital Adrenal Hyperplasia.
Journal: The New England journal of medicine
Published: October 23, 2024
Crinecerfont in Adult Congenital Adrenal Hyperplasia.
Journal: The New England journal of medicine
Published: October 23, 2024
Future Directions in the Management of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 16, 2024
CRH receptor antagonist crinecerfont - a promising new treatment option for patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Journal: Journal of pediatric endocrinology & metabolism : JPEM
Published: September 11, 2024
Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia.
Journal: The New England journal of medicine
Published: June 03, 2024
Last Updated: 10/31/2025